Company Filing History:
Years Active: 2001-2007
Title: Subramanian Sam Guhan: Innovator in Cancer Treatment
Introduction
Subramanian Sam Guhan is a notable inventor based in Niantic, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds useful in cancer treatment. With a total of 5 patents to his name, Guhan's work exemplifies innovation in medicinal chemistry.
Latest Patents
His latest patents include the enantiomers of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3H-imidazol-4-yl)-methyl]-4-[3-(3-hydroxy-3-methyl-but-1-ynyl)-phenyl]-1-methyl-1H-quinolin-2-one and salts thereof. This invention is particularly relevant for the treatment of hyperproliferative diseases, such as cancers, in mammals. The patent details processes for producing enantiomerically pure or optically enriched compounds using continuous chromatography, which enhances the efficacy of the treatment.
Career Highlights
Throughout his career, Guhan has worked with prominent companies in the pharmaceutical industry, including Pfizer Corporation and Chiral Technologies Europe. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Some of his notable coworkers include Robert Mark Guinn and R Mark Guinn. Their collaborative efforts have likely played a role in advancing research and development in their respective fields.
Conclusion
Subramanian Sam Guhan's contributions to cancer treatment through his innovative patents highlight the importance of research and development in pharmaceuticals. His work continues to impact the medical community positively.